ExoCoBio Company
.jpg)
ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.
Total Funding:
$47 000 000
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Funding Status:
Late Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Technology:
Regenerative Medicine
Investor Type:
For Profit
Last Funding Date:
2020-08-25
Investors Number:
16
Founded Date:
2017-01-01
Industry:
Longevity